Table 1.
Group
age 1954
Summary of thyroid abnommnalities in the Marshallese, 1981.
(Corrected
matched control value subtracted.)*
Est.
thy.
No. dose, rad
Ronge lap
<10
10-18
>18
Total
810-1150F
335- 810
335
556 av.
Ailingnae
<10
10-18
>18
Total
275-450
190
135
217 av.
Rong. + Ail.
Total nodules
Correc—
No.
%
ted 2%
17
3
3
23
77.3
25.0
9.1
(34.3
74.7
17.4
1.2
28.5
2
28.6
26.0
4
6
36.4
31.6
28.5
35.8
Carcinoma
No.
%
1
1
2
4
4.5
8.3
6.41
6.0
Correc-
ted %
3.6
8.3
5.4
5.2
Hypofunction**
Correc~
Now
Z%
ted 2Z
3
13.6
13.6
4
7
11.8
10.4
11.9
10.1
Total
lesions
Correc—
ted 2
88.3
17.3
13.2
38.7
26.3
<10
10-18
>18
Total
275-1150
190- 810
135- 335
482 av.
19
3.
7
29
65.5
23.1
15.9
«33.7
62.8
15.5
8.0
27.9
1
1
2
4
3.4
7.7
4.5
4.7
2.5
7.7
3.8
4.0
Utirik
<10
10-18
>18
Total
60-95
30-60
30
51 av.
5
3
9
li
4.7
14.2
11.4
9.1
5-2
6.7
3.5
4.6
i
1
1
3
1.6
4.8
1.3
1.8
0.7
4.8
0.6
1.1
2
1
2
5
0.9
1.3
0.7
0.8
1
1
9.0
5.2
8.8
5.0
37.3
30.2
3
10.3
10.3
5
8
11.4
9.3
11.1
9.0
73.2
i5.3
19.2
36.3
5.2
6.3
3.5
4.5
Matched controls, unexposed
<10
10-18
>18
Total
229
292
600
6
6
23
35
2.6
7.6
7.9
5.8
1
1
2
1.3
0.3
0.3
2.8tt
8.3
-—
om
2
*The cancer estimates are possibly underestimated since all unoperated nodules
were considered benign for these calculations. Occult carcinomas were not
included under carcinoma.
**No nodule cases with hypofunction are included.
Iv.)
(See Tables 1 and 2, Appendix
tThe lower dose estimates for the <10 group were used for in utero cases.
tiNo correction necessary.
w.
- 59 -